We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Diagnostic Microchip Inserted Under Skin Can Detect COVID-19

By LabMedica International staff writers
Posted on 14 Apr 2021
Researchers have created a microchip that can detect COVID-19 when inserted under the skin.

The implantable microchip developed by medical researchers at the US Pentagon’s Defense Advanced Research Projects Agency (DARPA; Arlington, VA, USA) can monitor the human body for signs of the SARS-CoV-2 virus. More...
Details of the revolutionary technology were shared on the 60 Minutes Show by Matthew Hepburn, an infectious disease physician and retired Army colonel who is heading DARPA’s response to the pandemic.

Hepburn told CBS that the microchip, embedded in a tissue-like gel, would continuously test the chip recipient’s blood for presence of the coronavirus. Upon detecting COVID-19, the chip would alert the patient to conduct a self-administered rapid blood test to confirm the positive result. According to Hepburn, DARPA had also developed a filter to remove the SARS-CoV-2 virus from the blood through a dialysis machine. The filter had been approved by the US Food and Drug Administration (FDA) and had already been used on 300 patients. Additionally, Hepburn compared the diagnostic microchip to a car’s “Check engine” alert and assured that DARPA’s chip would neither “track your every move” nor be administered via vaccines.

“It’s a sensor,” Hepburn told CBS. “That tiny green thing in there, you put it underneath your skin and what that tells you is that there are chemical reactions going on inside the body and that signal means you are going to have symptoms tomorrow. We can have that information in three to five minutes. As you truncate that time, as you diagnose and treat, what you do is you stop the infection in its tracks.”

Related Links:
Defense Advanced Research Projects Agency (DARPA)


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.